NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/18/2026
Back to search
Official data from USPTO
A ASTEX PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
75
Latest update
05/12/2026
Trademark type
Combined
Nice classes
44
Filing date
10/13/2011
Registration date
03/01/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/18/2026
Last transaction
05/12/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2012-05-00
First use in commerce
2012-05-00
Drawing code
3
Owner type
24
Owner location
CAMBRIDGE, GB
Examiner
KEAN, AMY C
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylized letter "A" with the stylized words "ASTEX PHARMACEUTICALS" appearing to the right. The gray tones are to indicate shading.
Holders and representatives
Holders
ASTEX THERAPEUTICS LIMITED
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc.
Representatives
Carole E. Klinger Fross Zelnick Lehrman & Zissu, P.C.
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Providing health care information via the Internet
Publications
History of USPTO decisions and trademark events.
75 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/18/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/18/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/17/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
02/10/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/02/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/22/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/22/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/22/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/22/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/15/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/15/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/15/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/15/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/15/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/10/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/12/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/12/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/12/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/15/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/15/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/15/2022
E815
TEAS SECTION 8 & 15 RECEIVED
02/24/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/01/2021
CORV
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
04/05/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/31/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
03/01/2016
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/26/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/23/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/12/2016
IUAF
USE AMENDMENT FILED
11/17/2015
EISU
TEAS STATEMENT OF USE RECEIVED
11/17/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/27/2015
EX5G
SOU EXTENSION 5 GRANTED
05/26/2015
EXT5
SOU EXTENSION 5 FILED
04/30/2015
EEXT
SOU TEAS EXTENSION RECEIVED
04/30/2015
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/11/2015
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/11/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/14/2014
EX4G
SOU EXTENSION 4 GRANTED
11/13/2014
EXT4
SOU EXTENSION 4 FILED
10/31/2014
EEXT
SOU TEAS EXTENSION RECEIVED
10/31/2014
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/14/2014
EX3G
SOU EXTENSION 3 GRANTED
05/13/2014
EXT3
SOU EXTENSION 3 FILED
05/08/2014
EEXT
SOU TEAS EXTENSION RECEIVED
05/08/2014
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/08/2013
EX2G
SOU EXTENSION 2 GRANTED
11/07/2013
EXT2
SOU EXTENSION 2 FILED
10/24/2013
EEXT
SOU TEAS EXTENSION RECEIVED
10/24/2013
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/05/2013
NOAC
CORRECTED NOA E-MAILED
06/05/2013
EX1G
SOU EXTENSION 1 GRANTED
06/04/2013
DPCC
DIVISIONAL PROCESSING COMPLETE
06/04/2013
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/21/2013
EXT1
SOU EXTENSION 1 FILED
05/17/2013
DRRR
DIVISIONAL REQUEST RECEIVED
05/17/2013
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
05/17/2013
EEXT
SOU TEAS EXTENSION RECEIVED
05/17/2013
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/20/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/25/2012
PUBO
PUBLISHED FOR OPPOSITION
09/25/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/05/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/20/2012
ALIE
ASSIGNED TO LIE
08/16/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/09/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/04/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/03/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/03/2012
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
02/07/2012
GPRA
PRIORITY ACTION E-MAILED
02/07/2012
CPRA
PRIORITY ACTION WRITTEN
02/07/2012
DOCK
ASSIGNED TO EXAMINER
02/01/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/19/2011
NWAP
NEW APPLICATION ENTERED
10/17/2011
Continuous trademark protection
Get notified about every new filing that threatens A ASTEX PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.